Richard A. C. Hughes

Guillain-Barré Syndrome (eBook, PDF)

• Format: PDF

Produktbeschreibung

Zur Zeit liegt uns keine Inhaltsangabe vor.

---

Dieser Download kann aus rechtlichen Gründen nur mit Rechnungsadresse in A, B, BG, CY, CZ, D, DK, EW, E, FIN, F, GR, HR, H, IRL, I, LT, L, LR, M, NL, PL, P, R, S, SLO, SK ausgeliefert werden.

Produktdetails

• Verlag: Springer London
• Seitenzahl: 308
• Erscheinungstermin: 6. Dezember 2012
• Englisch
• ISBN-13: 9781447131755
• Artikelnr.: 44000039

Inhaltsangabe

1 History and Definition.- Landry's Acute Ascending Paralysis.- Acute Febrile Polyneuritis.- Acute Infective Polyneuritis.- A Syndrome of Radiculoneuritis with Albumino-cytological Dissociation.- Guillain-Barré Syndrome or Landry's Ascending Paralysis.- Chronic Idiopathic Demyelinating Polyradiculoneuropathy.- Guillain-Barré Syndrome in History and the News.- Summary.- References.- 2 Immunobiology of the Peripheral Nervous System.- Wallerian Degeneration Versus Primary Demyelination.- Myelin.- Blood-Nerve Barrier.- Antigen Presentation in the Peripheral Nervous System.- Final Common Pathway of Immunologically Mediated Demyelination.- Antibody-Mediated Demyelination.- Antibody-Dependent Cell-Mediated Demyelination.- Cell-Mediated Cytotoxicity Causing Demyelination.- Delayed Hypersensitivity to Myelin Antigens Causing Demyelination.- Bystander Demyelination.- Summary.- References.- 3 Experimental Allergic Neuritis.- Experimental Allergic Encephalomyelitis.- Pathology of EAN.- Neurological Signs of EAN.- Experimental Autonomic Neuropathy.- Chronic Relapsing Experimental Allergic Neuritis.- Neurophysiology.- Cerebrospinal Fluid.- Identification of the Antigen Responsible for EAN.- Genetic Factors.- Antibody Production in EAN.- Cell-Mediated Immunity in EAN.- Galactocerebroside Neuritis.- Treatment of EAN.- Summary.- References.- 4 Pathology of Guillain-Barré Syndrome.- Autopsy Observations of Guillain-Barré Syndrome.- Biopsy Studies in Guillain-Barré Syndrome.- Immunohistochemical Studies of Nerves in GBS.- Remyelination.- Summary.- References.- 5 Epidemiology.- Swine Influenza Vaccine Epidemic.- Post-Rabies Vaccine Neuritis.- Viral Infections as Antecedent Events.- Mycoplasma, Bacterial and Other Infections as Antecedent Events.- Other Possible Precipitants ofGBS.- Summary.- References.- 6 Clinical Features of Guillain-Barré Syndrome.- Presentation.- Clinical Course.- Differential Diagnosis.- Miller Fisher Syndrome.- Autonomic Dysfunction.- Papilloedema.- Other Complications.- Summary.- References.- 7 Clinical Neurophysiology.- Frequency of Abnormalities of Motor Nerve Conduction.- Time Course of Nerve Conduction Abnormalities.- Sensory Nerve Conduction.- Axonal Degeneration in GBS.- Myokymia in GBS.- Evoked Potentials.- Electrophysiological Evidence and Prediction of Prognosis.- Mechanisms.- Summary.- References.- 8 Treatment of Guillain-Barré Syndrome.- Prognosis.- General Care.- Steroids.- Plasma Exchange.- Intravenous Immunoglobulin.- Immunosuppressive Drugs.- Rehabilitation.- Summary.- References.- 9 Immunology of Guillain-Barré Syndrome.- Cerebrospinal Fluid.- Diseases Associated with Guillain-Barré Syndrome.- HLA Associations.- Immunoglobulins, Complement and Immune Complexes.- Complexes.- Antibodies.- Cellular Immunity.- Summary.- References.- 10 Chronic Idiopathic Demyelinating Polyradiculoneuropathy.- Diagnostic Criteria.- Preceding Events.- Clinical Features.- Differential Diagnosis.- Evidence for CNS Involvement in CIDP.- Neurophysiology.- Cerebrospinal Fluid.- Pathology.- Immunology.- Treatment.- Summary.- References.- 11 Animal Models of Guillain-Barré Syndrome.- Marek's Disease.- Coonhound Paralysis.- Animal Idiopathic Polyradiculoneuropathy.- Cauda Equina Neuritis of the Horse.- Summary.- References.- 12 Other Inflammatory or Demyelinating Neuropathies.- Vasculitic Neuropathy.- Sarcoid Neuropathy.- Plasma Cell Dyscrasias and Neuropathy.- Leprosy.- Human Immunodeficiency Virus Infection and Neuropathy.- Summary.- References.- Appendix. Guillain-Barré Syndrome: A Short Guide for the Patient, Relativeand Friend.